Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Course of health care costs before and after psychiatric inpatient treatment: patient-reported vs. administrative records.

Zentner N, Baumgartner I, Becker T, Puschner B.

Int J Health Policy Manag. 2015 Jan 27;4(3):153-60. doi: 10.15171/ijhpm.2015.16. eCollection 2015 Mar.

2.

Utility of Two PANSS 5-Factor Models for Assessing Psychosocial Outcomes in Clinical Programs for Persons with Schizophrenia.

Jerrell JM, Hrisko S.

Schizophr Res Treatment. 2013;2013:705631. doi: 10.1155/2013/705631. Epub 2013 Dec 5.

3.

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis.

Ye W, Ascher-Svanum H, Tanji Y, Flynn JA, Takahashi M, Conley RR.

Neuropsychiatr Dis Treat. 2012;8:259-66. doi: 10.2147/NDT.S25662. Epub 2012 Jun 18.

4.

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan.

Ye W, Ascher-Svanum H, Flynn JA, Tanji Y, Takahashi M.

Clinicoecon Outcomes Res. 2012;4:13-9. doi: 10.2147/CEOR.S25968. Epub 2012 Jan 13.

5.

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.

Johnsen E, Kroken RA, Wentzel-Larsen T, Jørgensen HA.

BMC Psychiatry. 2010 Mar 24;10:26. doi: 10.1186/1471-244X-10-26.

6.

Effectiveness of second generation antipsychotics: a systematic review of randomized trials.

Johnsen E, Jørgensen HA.

BMC Psychiatry. 2008 Apr 25;8:31. doi: 10.1186/1471-244X-8-31. Review.

7.

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

Zhu B, Ascher-Svanum H, Faries DE, Correll CU, Kane JM.

BMC Psychiatry. 2008 Apr 4;8:19. doi: 10.1186/1471-244X-8-19.

8.

Defining and assessing adherence to oral antipsychotics: a review of the literature.

Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL.

Schizophr Bull. 2006 Oct;32(4):724-42. Epub 2006 May 17. Review.

9.

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.

Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J.

BMC Psychiatry. 2005 May 27;5:26.

10.
Items per page

Supplemental Content

Write to the Help Desk